English

Kedem Pharmaceuticals Inc.

EDGAR

Quarterly report (10-Q) · filed 2013-01-02

30 filing records in this dataset, filed from 2007-04-23 to 2013-01-02. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2011-08-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-636 thousand USD

2011-08-31 · USD

Exact inputs and evidence

Operating Cash Flow: -635749 USD Source

Cash and cash equivalents: 1.39 million USD 2011-08-31 Source
Exact value

1393916 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-01-02.

Financial data available through: 2011-05-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2011-05-31
operating income: No compatible figures in this window
Net income: 5 of 11 periods available· newest 2011-05-31
Operating cash flow: 3 of 11 periods available· newest 2009-05-31
Capital expenditure: 3 of 11 periods available· newest 2009-05-31
Total assets: 5 of 11 periods available· newest 2011-05-31
Total liabilities: 2 of 11 periods available· newest 2008-05-31
Current assets: 4 of 11 periods available· newest 2011-05-31
Current liabilities: 5 of 11 periods available· newest 2011-05-31
Cash and cash equivalents: 5 of 11 periods available· newest 2011-05-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2009-06-01 – 2010-05-31
Current period

USD 0

2010-06-01 – 2011-05-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2009-06-01 – 2010-05-31
Inspect prior input Prior source
0 USD · 2010-06-01 – 2011-05-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Kedem Pharmaceuticals Inc. · 2011-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2010-06-01 to 2011-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2010-06-01 to 2011-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001415408-11-000399.txt#4023 Input fundies:Revenue: 0 USD (2009-06-01 to 2010-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001415408-11-000266.txt#4306
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 2.19 million

Prior period

−USD 1.98 million

2009-06-01 – 2010-05-31
Current period

−USD 4.17 million

2010-06-01 – 2011-05-31

Exact inputs and evidence

-4171986 − -1978882 = -2193104 USD

-1978882 USD · 2009-06-01 – 2010-05-31
Inspect prior input Prior source
-4171986 USD · 2010-06-01 – 2011-05-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Kedem Pharmaceuticals Inc. · 2011-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Year-over-year change in Net income: -2193104 USD Concept: fundies:NetIncome Period: 2010-06-01 to 2011-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -4171986 USD (2010-06-01 to 2011-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001415408-11-000399.txt#4549 Input fundies:NetIncome: -1978882 USD (2009-06-01 to 2010-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001415408-11-000266.txt#4690
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2010-06-01 – 2011-05-31

Revenue USD 0
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 4.17 million

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2007 Not shown: operating income or net income is not reported.
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.
2011 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2007 2006-06-01 – 2007-05-31	Unavailable	Unavailable	Unavailable	-61174	-38502 Derived	Source 2006-06-01 – 2007-05-31: 0 USD Inspect Revenue Open source 2006-06-01 – 2007-05-31: -61174 USD Inspect Net Income Open source 2006-06-01 – 2007-05-31: -38502 USD Inspect Operating Cash Flow Open source 2006-06-01 – 2007-05-31: 0 USD Inspect Capital Expenditure Open source
2008 2007-06-01 – 2008-05-31	Unavailable	Unavailable	Unavailable	-65168	-31799 Derived	Source 2007-06-01 – 2008-05-31: 0 USD Inspect Revenue Open source 2007-06-01 – 2008-05-31: -65168 USD Inspect Net Income Open source 2007-06-01 – 2008-05-31: -31799 USD Inspect Operating Cash Flow Open source 2007-06-01 – 2008-05-31: 0 USD Inspect Capital Expenditure Open source
2009 2008-06-01 – 2009-05-31	Unavailable	Unavailable	Unavailable	-1978882	-82949 Derived	Source 2008-06-01 – 2009-05-31: 0 USD Inspect Revenue Open source 2008-06-01 – 2009-05-31: -1978882 USD Inspect Net Income Open source 2008-06-01 – 2009-05-31: -79180 USD Inspect Operating Cash Flow Open source 2008-06-01 – 2009-05-31: 3769 USD Inspect Capital Expenditure Open source
2010 2009-06-01 – 2010-05-31	Unavailable	Unavailable	Unavailable	-1978882	Unavailable	Source 2009-06-01 – 2010-05-31: 0 USD Inspect Revenue Open source 2009-06-01 – 2010-05-31: -1978882 USD Inspect Net Income Open source
2011 2010-06-01 – 2011-05-31	Unavailable	Unavailable	Unavailable	-4171986	Unavailable	Source 2010-06-01 – 2011-05-31: 0 USD Inspect Revenue Open source 2010-06-01 – 2011-05-31: -4171986 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2011

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20072007-05-31	Revenue	Revenue: 0 Open source
20082008-05-31	Revenue	Revenue: 0 Open source
20092009-05-31	Revenue	Revenue: 0 Open source
20102010-05-31	Revenue	Revenue: 0 Open source
20112011-05-31	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20072007-05-31	Year over year	No prior comparable period	Revenue: 0 Open source
20082008-05-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20092009-05-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-05-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20112011-05-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2007-05-31	Operating margin	Not reported	Revenue: 0 Open source
2008-05-31	Operating margin	Not reported	Revenue: 0 Open source
2009-05-31	Operating margin	Not reported	Revenue: 0 Open source
2010-05-31	Operating margin	Not reported	Revenue: 0 Open source
2011-05-31	Operating margin	Not reported	Revenue: 0 Open source
20072007-05-31	Net margin	Not reported	Net Income: -61174 Open source Revenue: 0 Open source
20082008-05-31	Net margin	Not reported	Net Income: -65168 Open source Revenue: 0 Open source
20092009-05-31	Net margin	Not reported	Net Income: -1978882 Open source Revenue: 0 Open source
20102010-05-31	Net margin	Not reported	Net Income: -1978882 Open source Revenue: 0 Open source
20112011-05-31	Net margin	Not reported	Net Income: -4171986 Open source Revenue: 0 Open source
20072007-05-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -38502 Open source Capital Expenditure: 0 Open source
20082008-05-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -31799 Open source Capital Expenditure: 0 Open source
20092009-05-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -79180 Open source Capital Expenditure: 3769 Open source
20102010-05-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20112011-05-31	Free cash flow margin	Not reported	Revenue: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -79.2K 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-05-31	Operating cash flow	-38502	Operating Cash Flow: -38502 Open source
20082008-05-31	Operating cash flow	-31799	Operating Cash Flow: -31799 Open source
20092009-05-31	Operating cash flow	-79180	Operating Cash Flow: -79180 Open source
20102010-05-31	Operating cash flow	Not reported	No source recorded
20112011-05-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -82.9K 2009

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-05-31	Free cash flow	-38502	Operating Cash Flow: -38502 Open source Capital Expenditure: 0 Open source
20082008-05-31	Free cash flow	-31799	Operating Cash Flow: -31799 Open source Capital Expenditure: 0 Open source
20092009-05-31	Free cash flow	-82949	Operating Cash Flow: -79180 Open source Capital Expenditure: 3769 Open source
20102010-05-31	Free cash flow	Unavailable	No source recorded
20112011-05-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

1,722.1% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20072007-05-31	Liabilities / assets	293.9%	Total Liabilities: 55653 Open source Total Assets: 18939 Open source
20082008-05-31	Liabilities / assets	1,722.1%	Total Liabilities: 98608 Open source Total Assets: 5726 Open source
2009-05-31	Liabilities / assets	Not reported	Total Assets: 354091 Open source
2010-05-31	Liabilities / assets	Not reported	Total Assets: 2512800 Open source
2011-05-31	Liabilities / assets	Not reported	Total Assets: 2713479 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.72× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2007-05-31	Current assets / current liabilities	Not reported	Current Liabilities: 51121 Open source
20082008-05-31	Current assets / current liabilities	0.06×	Current Assets: 5726 Open source Current Liabilities: 98608 Open source
20092009-05-31	Current assets / current liabilities	4.82×	Current Assets: 348608 Open source Current Liabilities: 72350 Open source
20102010-05-31	Current assets / current liabilities	0.77×	Current Assets: 1109148 Open source Current Liabilities: 1441198 Open source
20112011-05-31	Current assets / current liabilities	0.72×	Current Assets: 1526094 Open source Current Liabilities: 2128789 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2006-06-01 – 2007-05-31	−USD 61,174 Exact value Exact value: -61174 USD 2006-06-01 – 2007-05-31: -61174 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kedem Pharmaceuticals Inc. · 2007-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Net Income: -61174 USD Concept: fundies:NetIncome Period: 2006-06-01 to 2007-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3ANetIncome&period=2007-05-31&surface=latest&period_type=duration&start=2006-06-01&unit=USD&dimensions= Input fundies:NetIncome: -61174 USD (2006-06-01 to 2007-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001415408-11-000055.txt#3973 The citation records this snapshot. The page link may show a newer release later.	−USD 38,502 Exact value Exact value: -38502 USD 2006-06-01 – 2007-05-31: -38502 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kedem Pharmaceuticals Inc. · 2007-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Operating Cash Flow: -38502 USD Concept: fundies:OperatingCashFlow Period: 2006-06-01 to 2007-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3AOperatingCashFlow&period=2007-05-31&surface=latest&period_type=duration&start=2006-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38502 USD (2006-06-01 to 2007-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2887 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2006-06-01 – 2007-05-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kedem Pharmaceuticals Inc. · 2007-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2006-06-01 to 2007-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3ACapitalExpenditure&period=2007-05-31&surface=latest&period_type=duration&start=2006-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2006-06-01 to 2007-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2945 The citation records this snapshot. The page link may show a newer release later.	−USD 38,502 Calculation and evidence -38502 − 0 USD Exact free cash flow: -38502 USD 2006-06-01 – 2007-05-31: -38502 USD · Inspect Operating Cash Flow · Source 2006-06-01 – 2007-05-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kedem Pharmaceuticals Inc. · 2007-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Free cash flow: -38502 USD Concept: free-cash-flow Period: 2006-06-01 to 2007-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38502 USD (2006-06-01 to 2007-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2887 Input fundies:CapitalExpenditure: 0 USD (2006-06-01 to 2007-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2945 The citation records this snapshot. The page link may show a newer release later.
2008 2007-06-01 – 2008-05-31	−USD 65,168 Exact value Exact value: -65168 USD 2007-06-01 – 2008-05-31: -65168 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kedem Pharmaceuticals Inc. · 2008-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Net Income: -65168 USD Concept: fundies:NetIncome Period: 2007-06-01 to 2008-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3ANetIncome&period=2008-05-31&surface=latest&period_type=duration&start=2007-06-01&unit=USD&dimensions= Input fundies:NetIncome: -65168 USD (2007-06-01 to 2008-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001415408-11-000055.txt#3973 The citation records this snapshot. The page link may show a newer release later.	−USD 31,799 Exact value Exact value: -31799 USD 2007-06-01 – 2008-05-31: -31799 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kedem Pharmaceuticals Inc. · 2008-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Operating Cash Flow: -31799 USD Concept: fundies:OperatingCashFlow Period: 2007-06-01 to 2008-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3AOperatingCashFlow&period=2008-05-31&surface=latest&period_type=duration&start=2007-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31799 USD (2007-06-01 to 2008-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2887 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2007-06-01 – 2008-05-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kedem Pharmaceuticals Inc. · 2008-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2007-06-01 to 2008-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3ACapitalExpenditure&period=2008-05-31&surface=latest&period_type=duration&start=2007-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2007-06-01 to 2008-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2945 The citation records this snapshot. The page link may show a newer release later.	−USD 31,799 Calculation and evidence -31799 − 0 USD Exact free cash flow: -31799 USD 2007-06-01 – 2008-05-31: -31799 USD · Inspect Operating Cash Flow · Source 2007-06-01 – 2008-05-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kedem Pharmaceuticals Inc. · 2008-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Free cash flow: -31799 USD Concept: free-cash-flow Period: 2007-06-01 to 2008-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31799 USD (2007-06-01 to 2008-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2887 Input fundies:CapitalExpenditure: 0 USD (2007-06-01 to 2008-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2945 The citation records this snapshot. The page link may show a newer release later.
2009 2008-06-01 – 2009-05-31	−USD 1.98 million Exact value Exact value: -1978882 USD 2008-06-01 – 2009-05-31: -1978882 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kedem Pharmaceuticals Inc. · 2009-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Net Income: -1978882 USD Concept: fundies:NetIncome Period: 2008-06-01 to 2009-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3ANetIncome&period=2009-05-31&surface=latest&period_type=duration&start=2008-06-01&unit=USD&dimensions= Input fundies:NetIncome: -1978882 USD (2008-06-01 to 2009-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001415408-11-000399.txt#4549 The citation records this snapshot. The page link may show a newer release later.	−USD 79,180 Exact value Exact value: -79180 USD 2008-06-01 – 2009-05-31: -79180 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kedem Pharmaceuticals Inc. · 2009-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Operating Cash Flow: -79180 USD Concept: fundies:OperatingCashFlow Period: 2008-06-01 to 2009-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3AOperatingCashFlow&period=2009-05-31&surface=latest&period_type=duration&start=2008-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -79180 USD (2008-06-01 to 2009-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2887 The citation records this snapshot. The page link may show a newer release later.	USD 3,769 Exact value Exact value: 3769 USD 2008-06-01 – 2009-05-31: 3769 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kedem Pharmaceuticals Inc. · 2009-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Capital Expenditure: 3769 USD Concept: fundies:CapitalExpenditure Period: 2008-06-01 to 2009-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3ACapitalExpenditure&period=2009-05-31&surface=latest&period_type=duration&start=2008-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3769 USD (2008-06-01 to 2009-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2945 The citation records this snapshot. The page link may show a newer release later.	−USD 82,949 Calculation and evidence -79180 − 3769 USD Exact free cash flow: -82949 USD 2008-06-01 – 2009-05-31: -79180 USD · Inspect Operating Cash Flow · Source 2008-06-01 – 2009-05-31: 3769 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kedem Pharmaceuticals Inc. · 2009-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Free cash flow: -82949 USD Concept: free-cash-flow Period: 2008-06-01 to 2009-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -79180 USD (2008-06-01 to 2009-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2887 Input fundies:CapitalExpenditure: 3769 USD (2008-06-01 to 2009-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001062993-09-003429.txt#2945 The citation records this snapshot. The page link may show a newer release later.
2010 2009-06-01 – 2010-05-31	−USD 1.98 million Exact value Exact value: -1978882 USD 2009-06-01 – 2010-05-31: -1978882 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kedem Pharmaceuticals Inc. · 2010-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Net Income: -1978882 USD Concept: fundies:NetIncome Period: 2009-06-01 to 2010-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3ANetIncome&period=2010-05-31&surface=latest&period_type=duration&start=2009-06-01&unit=USD&dimensions= Input fundies:NetIncome: -1978882 USD (2009-06-01 to 2010-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001415408-11-000266.txt#4690 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2011 2010-06-01 – 2011-05-31	−USD 4.17 million Exact value Exact value: -4171986 USD 2010-06-01 – 2011-05-31: -4171986 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kedem Pharmaceuticals Inc. · 2011-05-31 Kedem Pharmaceuticals Inc. (edgar:1376228) Net Income: -4171986 USD Concept: fundies:NetIncome Period: 2010-06-01 to 2011-05-31 Values: Latest reported Published: 2026-11-02T18:22:09Z Snapshot: 387021c557ab4a4d1d6dee4794feee7a30bd1cf10d8efd5c153382afcc0105ba Dimensions: Consolidated View: https://fundies.io/companies/edgar/1376228/explain?concept=fundies%3ANetIncome&period=2011-05-31&surface=latest&period_type=duration&start=2010-06-01&unit=USD&dimensions= Input fundies:NetIncome: -4171986 USD (2010-06-01 to 2011-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1376228/0001415408-11-000399.txt#4549 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

30 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001376228, 1376228, edgar:1376228

Also known as Acting Scout Inc., GLOBAL HEALTH VENTURES INC., Goldtown Investments Corp.

Kedem Pharmaceuticals Inc.

Latest quarter

Revenue

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2011 2010-06-01 – 2011-05-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation